X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (541) 541
Publication (95) 95
Book Review (19) 19
Book Chapter (10) 10
Government Document (3) 3
Conference Proceeding (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (339) 339
index medicus (332) 332
postexposure prophylaxis (259) 259
animals (239) 239
immunology (150) 150
female (137) 137
infectious diseases (137) 137
postexposure protection (133) 133
male (130) 130
prevention (116) 116
vaccines (105) 105
infection (98) 98
health aspects (96) 96
rabies (95) 95
nonhuman-primates (79) 79
viruses (79) 79
vaccination (78) 78
microbiology (77) 77
ebola virus (74) 74
adult (72) 72
virology (71) 71
hiv infections - prevention & control (70) 70
research (69) 69
prophylaxis (68) 68
rabies - prevention & control (68) 68
public health (67) 67
hemorrhagic-fever (63) 63
medicine, research & experimental (63) 63
mice (63) 63
hiv (62) 62
infections (61) 61
article (59) 59
vaccine (57) 57
virus diseases (56) 56
immunization (55) 55
analysis (51) 51
pharmacology & pharmacy (51) 51
human immunodeficiency virus--hiv (50) 50
risk factors (50) 50
disease transmission (49) 49
united-states (48) 48
public, environmental & occupational health (47) 47
transmission (46) 46
disease models, animal (45) 45
exposure (44) 44
care and treatment (42) 42
human-immunodeficiency-virus (41) 41
adolescent (40) 40
epidemiology (40) 40
guinea-pigs (40) 40
antiviral agents (39) 39
hiv infection (39) 39
hiv infections - transmission (39) 39
post-exposure prophylaxis (38) 38
rabies vaccines - administration & dosage (38) 38
middle aged (37) 37
medicine (36) 36
postexposure treatment (36) 36
disease (35) 35
rabies vaccines - immunology (34) 34
rabies virus - immunology (34) 34
antibodies (33) 33
hemorrhagic fever, ebola - virology (33) 33
pathogenesis (33) 33
pre-exposure prophylaxis (33) 33
usage (33) 33
abridged index medicus (32) 32
postexposure (32) 32
risk (32) 32
anti-hiv agents - therapeutic use (31) 31
antiviral agents - therapeutic use (31) 31
dogs (31) 31
ebola virus infections (31) 31
medical research (31) 31
child (30) 30
drug therapy (30) 30
hemorrhagic fever, ebola - prevention & control (30) 30
immunogenicity (30) 30
medicine, general & internal (30) 30
monoclonal antibodies (30) 30
young adult (30) 30
dendritic cells (29) 29
virus (29) 29
disease prevention (28) 28
ebolavirus - immunology (28) 28
allergy and immunology (27) 27
hemorrhagic fever, ebola - epidemiology (27) 27
immunoglobulins (27) 27
medicine & public health (27) 27
marburg virus (26) 26
mortality (26) 26
anthrax (25) 25
ebola (25) 25
epidemics (25) 25
proteins (25) 25
rabies - epidemiology (25) 25
research article (25) 25
studies (25) 25
filovirus (24) 24
hemorrhagic fever, ebola - drug therapy (24) 24
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (539) 539
French (4) 4
German (3) 3
Spanish (2) 2
Hungarian (1) 1
Japanese (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 2014, Volume 508, Issue 7496, pp. 402 - 405
Filoviruses are emerging pathogens and causative agents of viral haemorrhagic fever. Case fatality rates of filovirus disease outbreaks are among the highest... 
NONHUMAN-PRIMATES | CHALLENGE | REPLICATION | HEMORRHAGIC-FEVER | MARBURG-VIRUS | MULTIDISCIPLINARY SCIENCES | POSTEXPOSURE PROTECTION | MOUSE MODEL | ANTIVIRAL ACTIVITY | EBOLA-VIRUS INFECTION | SMALL-MOLECULE INHIBITOR | Antiviral Agents - pharmacokinetics | DNA-Directed RNA Polymerases - antagonists & inhibitors | Hemorrhagic Fever, Ebola - prevention & control | Marburg Virus Disease - virology | Purine Nucleosides - pharmacology | Humans | Purine Nucleosides - pharmacokinetics | Ebolavirus - drug effects | Time Factors | Antiviral Agents - chemistry | Hemorrhagic Fever, Ebola - virology | Marburg Virus Disease - prevention & control | Disease Models, Animal | Antiviral Agents - pharmacology | Administration, Oral | Purine Nucleosides - chemistry | Filoviridae - drug effects | Injections, Intramuscular | Antiviral Agents - administration & dosage | Purine Nucleosides - administration & dosage | RNA - biosynthesis | Animals | Filoviridae Infections - prevention & control | Adenosine - analogs & derivatives | Filoviridae Infections - virology | Marburgvirus - drug effects | Filoviridae - enzymology | DNA-Directed RNA Polymerases - metabolism | Macaca fascicularis - virology | Prevention | Pharmaceutical research | Antiviral agents | Research | RNA virus infections | Nucleoside analogs | Enzymes | Viruses | Infections | Disease | Laboratory animals
Journal Article
Antiviral Research, ISSN 0166-3542, 08/2016, Volume 132, pp. 141 - 148
Journal Article
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 09/2019, Volume 220, Issue 8, pp. 1281 - 1289
Abstract Lassa fever is a frequently severe human disease that is endemic to several countries in West Africa. To date, no licensed vaccines are available to... 
Lassa | INFECTIOUS DISEASES | postexposure | single-cycle replication | vaccine | MICROBIOLOGY | INFECTION | GUINEA-PIGS | IMMUNOLOGY | EPIDEMIOLOGY | virus replicon particle | FEVER
Journal Article
Vaccine, ISSN 0264-410X, 2011, Volume 29, Issue 16, pp. 2968 - 2977
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 10/2006, Volume 194, Issue 7, pp. 904 - 911
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2008, Volume 105, Issue 31, pp. 10889 - 10894
Journal Article
Journal of NeuroVirology, ISSN 1355-0284, 10/2018, Volume 24, Issue 5, pp. 606 - 615
Rabies virus is a neurotropic lyssavirus which is 100% fatal in its pathogenic form when reaching unprotected CNS tissues. Death can be prevented by mechanisms... 
Neurology | Neurosciences | Immunization | Biomedicine | Immunology | Long-term protection | Neurovirology | Infectious Diseases | Rabies virus | Virology | SYSTEM | CELLS | POSTEXPOSURE PROPHYLAXIS | BARRIER PERMEABILITY CHANGES | INDUCTION | NEUROSCIENCES | MAINTENANCE | VIROLOGY | MEMORY | long-term protection | neurovirology | immunization
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 514, Issue 7520, pp. 47 - 53
Journal Article
SCIENCE TRANSLATIONAL MEDICINE, ISSN 1946-6234, 08/2013, Volume 5, Issue 199
Ebola virus (EBOV) remains one of the most lethal transmissible infections and is responsible for high fatality rates and substantial morbidity during sporadic... 
NONHUMAN-PRIMATES | MEDICINE, RESEARCH & EXPERIMENTAL | POSTEXPOSURE PROTECTION | DISEASE | CELL BIOLOGY
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2014, Volume 111, Issue 48, pp. 17182 - 17187
Ebola virus (EBOV) and related filoviruses cause severe hemorrhagic fever, with up to 90% lethality, and no treatments are approved for human use. Multiple... 
Ebola virus | Polysaccharides | Cocktails | Antibodies | Monoclonal antibodies |